We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+1.5%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$21.4B
AUM Growth
-$3.07B
Cap. Flow
-$3.45B
Cap. Flow %
-16.12%
Top 10 Hldgs %
34%
Holding
335
New
40
Increased
37
Reduced
44
Closed
34

Top Buys

Rank Stock Value
1
ARMK icon
Aramark
ARMK
+$209M
2
KSU
Kansas City Southern
KSU
+$193M
3
HWM icon
Howmet Aerospace
HWM
+$184M
4
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$172M
5
TMUS icon
T-Mobile US
TMUS
+$160M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.42B
2
MXIM
Maxim Integrated Products
MXIM
+$476M
3
WTW icon
Willis Towers Watson
WTW
+$468M
4
WORK
Slack Technologies, Inc.
WORK
+$462M
5
AON icon
Aon
AON
+$371M

Sector Composition

Rank Sector Weight
1 Healthcare 28.83%
2 Technology 13.3%
3 Industrials 11.55%
4 Communication Services 11.47%
5 Financials 11.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SVFA
201
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$2.44M 0.01%
250,000
– –
HIII
202
DELISTED
Hudson Executive Investment Corp. III Class A Common Stock
HIII
$2.43M 0.01%
250,000
– –
LOKM
203
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
$2.42M 0.01%
250,000
– –
ANAC
204
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
$1.95M 0.01%
200,000
– –
RGTI icon
205
Rigetti Computing
RGTI
$5.98B
$1.94M 0.01%
200,000
– –
ORTX
206
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$1.53M 0.01%
66,520
-255,023
-79% -$7.59M
LDHA
207
DELISTED
LDH Growth Corp I Class A Ordinary Shares
LDHA
$1.47M 0.01%
150,000
– –
AEON icon
208
AEON Biopharma
AEON
$9.58M
$1.46M 0.01%
2,083
– –
DCRCW
209
DELISTED
Decarbonization Plus Acquisition Corporation III Warrant
DCRCW
$1.4M 0.01%
666,666
– –
TMAC
210
DELISTED
The Music Acquisition Corporation
TMAC
$1.22M 0.01%
125,000
– –
NSTD
211
DELISTED
Northern Star Investment Corp. IV
NSTD
$980K ﹤0.01%
100,000
– –
NSTC
212
DELISTED
Northern Star Investment Corp. III
NSTC
$974K ﹤0.01%
100,000
– –
RUM icon
213
RUM Group Inc
RUM
$4.49B
$971K ﹤0.01%
100,000
– –
BRMK.WS
214
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$861K ﹤0.01%
7,174,613
– –
GRFS
215
Grifois
GRFS
$5.44B
$776K ﹤0.01%
53,133
-119,605
-69% -$1.81M
ASPC
216
DELISTED
Alpha Capital Acquisition Co
ASPC
$774K ﹤0.01%
79,598
– –
SLAM
217
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$687K ﹤0.01%
70,508
– –
GOL
218
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$655K ﹤0.01%
85,838
– –
SPAQ
219
DELISTED
Spartan Acquisition Corp. III
SPAQ
$593K ﹤0.01%
60,053
– –
SEPAW
220
DELISTED
SEP Acquisition Corp Warrants
SEPAW
$433K ﹤0.01%
+866,250
New +$484K
SHQAW
221
DELISTED
Shelter Acquisition Corporation I Warrants
SHQAW
$412K ﹤0.01%
+825,000
New +$427K
ASZ.WS
222
DELISTED
Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
ASZ.WS
$394K ﹤0.01%
375,000
– –
TINV.WS
223
DELISTED
Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TINV.WS
$378K ﹤0.01%
540,000
– –
REVHW
224
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Warrant.
REVHW
$371K ﹤0.01%
400,000
– –
KAHC.WS
225
DELISTED
KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
KAHC.WS
$360K ﹤0.01%
375,000
– –
7 8
9
10 11

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q3 2021 Portfolio in Review

As of Q3 2021, Thomas Steyer held 335 positions worth $21.4B, down 13% from $24.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Thomas Steyer withdrew a net $3.45B in Q3 2021, closing 34 positions and reducing 44 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $1.42B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 30% a quarter earlier, followed by Technology and Industrials.

Against the trend, Thomas Steyer opened a new position in Macquarie Infrastructure Holdings, LLC worth $177M.

  • Thomas Steyer's largest Q3 2021 buy was Macquarie Infrastructure Holdings, LLC: 4,361,050 shares worth $177M.
  • Thomas Steyer added most to Aramark in Q3 2021, an estimated $209M increase.
  • Thomas Steyer's biggest Q3 2021 reduction was Willis Towers Watson, cutting an estimated $468M.
  • Thomas Steyer fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.42B.
  • Thomas Steyer's ten largest holdings make up 34% of its $21.4B portfolio in Q3 2021.
  • Thomas Steyer opened 40 new positions and closed 34 in Q3 2021.
  • Thomas Steyer's portfolio value fell 13% quarter-over-quarter to $21.4B.

Based on Farallon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.